The precipitation of fibrinogen from plasma by means of heparin was reported by Smith (1955) , and the formation of complexes between acidic mucopolysaccharides and protein (Anderson, 1963) has been used in a range of studies, for example, in ,B lipoprotein (Burstein and Samaille, 1958 ) and on desoxyribonucleoprotein (Kent, Hichens, and Ward, 1958) . The observation of fibrinogenolysis and fibrinolysis in one of the heparin complexes prepared from fresh human plasma at low ionic strength (Green, 1959) has been adapted for clinical study. Lysis in this system is more rapid than any hitherto reported, and it was felt that an isolating technique would be of value in defining variable factors and in applying objective methods of measurement (Green and Thomson, 1962) .
METHODS
Fractionation was originally carried out by the step-wise addition of either acid to diluted heparinized plasma or heparin to diluted plasma atpH 6-8. For routine purposes it is carried out in one standard procedure, by adding 1 volume of plasma to 2 volumes of 6 x 10-3N HCl containing 12-5 units of heparin per millilitre. The complex so produced is spun down, washed rapidly, and re-dissolved in buffer.
ESTIMATION OF VISUAL LYSIS ACTIVITY The precipitate is dissolved in 1 volume of barbitone-NaCl buffer (Owren, 1947) , pH 7 5, and 0-25 ml. aliquots made up to 0 5 ml. with buffer and clotted at room temperature with 0-5 ml. thrombin solution (10 N.I.H. units/ml.). The resultant clot is incubated in a water bath at 37°C., and the lysis time recorded as the time required for complete disappearance of the clot. Anderson's (1962) technique has been modified to study fibrinogenolysis and fibrinolysis. In the latter case, 1 ml. of the above redissolved fraction is clotted with 0-2 ml. thrombin solution (20 N.I.H. units/ml.) and incubated for two hours at 25°C. or one hour at 37°C. Then 1 ml. of 40% urea is added, and, when any remaining fibrin has dissolved, 1-8 ml. 10% trichloracetic acid (T.C.A.) is also added. The control 1 ml. sample receives 1 ml. 40 % urea, 0-2 ml. thrombin, and 1-8 ml. T.C.A. immediately. The increase in tyrosine and tryptophane peptides in the supernatant is measured at 280 um. on a Unicam model SP 500 and expressed as tmol tyrosine.
ESTIMATION OF PROTEOLYTIC ACTIVITY
MEASUREMENT OF ESTERASE ACTIVITY The precipitate from 1 volume of plasma is redissolved in 0-1M Tris buffer,pH 7-5,0-33-1-0 volume, as required, and incubated for 10 minutes at 37°C. to allow activation. Amounts each of 1 ml. are incubated as above with I ml. of 20 ,umol/ml. tosyl arginine methyl ester or lysine ethyl ester, precipitated with 2 ml. 10% T.C.A., and the residual ester measured as the ferric hydroxamate (Brown, 1960) .
OTHER PROCEDURES Total protein and total minus fibrin can be measured by the biuret method of Wolfson, Cohn, Calvary, and Ichiba (1948) . Lysis is inhibited by using 1 x 10-3M e-amino-caproic acid.
RESULTS
The fraction varies in composition and solubility with the anticoagulant employed, but will contain on average 50 to 75 % of plasma fibrinogen and about 20% of the plasminogen. Electrophoresis of the re-precipitated fraction on cellulose acetate at pH 8-6 shows a main fibrinogen band, some , globulin, and virtually no other fractions (Fig. 1) .
The reproducibility of activity in this system dependsuponthree main factors. (1) The constancy of the ratio of decalcifying agent to plasma (variation can be minimized by using a three-or four-fold excess of E.D.T.A., i.e., 1 ml. M/20 E.D.T.A. to 10 ml. blood). (2) The control of the temperature of manipulation, the extreme lability of the system has required operation as near 0°C. as possible to minimize loss of activity in shed blood and activation once the precipitate is formed. Reducing the pH of blood below 7-0, and the incorporation of lysine methyl ester in the anticoagulant diminish the lability in shed blood but these measures have not been fully tried. (3) (Derechin, 1961 Inhibition by 1 x 10-3M E-amino-caproic acid, the increase in proteolytic and esterolytic activity on clotting, and the lability of activity in shed blood suggest that plasma activator is being measured. Evidence of activation as such, however, has been obtained only from esterase studies in highly active specimens.
While the conditions of fractionation are empirically chosen, the objective methods of end-point determination offer a precision which is lacking in visual lytic methods. Esterase methods appear to be capable of quantitation but at the moment they are insensitive to 'normal' values. The proteolytic method is simple and flexible enough to cover a wide range of values but is dependent upon fibrinogen levels. For comparative purposes additional fibrinogen could be added as substrate (Anderson, 1962) , or alternatively, urokinase might be used to standardize the values obtained at varying substrate levels in the fraction. These possibilities are being explored.
